Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN87061665
ISRCTN87061665
Completed
N/A

A pilot study to determine the impact of therapeutic Human Immunodeficiency Virus (HIV) vaccination followed by a scheduled interruption of antiretroviral therapy on HIV-specific immune function by a scheduled virologic rebound in patients with prolonged viral suppression

Ottawa Hospital Research Institute (Canada)0 sites60 target enrollmentNovember 16, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHuman Immunodeficiency Virus (HIV)Infections and InfestationsHuman immunodeficiency virus (HIV)

Overview

Phase
N/A
Intervention
Not specified
Conditions
Human Immunodeficiency Virus (HIV)
Sponsor
Ottawa Hospital Research Institute (Canada)
Enrollment
60
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 16, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ottawa Hospital Research Institute (Canada)

Eligibility Criteria

Inclusion Criteria

  • •1\. HIV positive CD4 greater than 500
  • •2\. Age 18 years and older, either sex
  • •3\. CD4 nadir greater than 250
  • •4\. Viral load less than 50 for greater than 2 years
  • •5\. Receiving a Protease Inhibitor (PI) or Non\-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Exclusion Criteria

  • •1\. Patients with previous Acquired Immunodeficiency Syndrome (AIDS) defining opportunistic infections, previous cancer chemotherapy or other system immunosuppressive therapy
  • •2\. Patients with concurrent infections with hepatitis C or hepatitis B or any other acute illness

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
A pilot study to evaluate the therapeutic efficacy of kurosani ommumsathu (internal) in the management ofthookaminmai (insomnia)Health Condition 1: null- THOOKAMINMAI(INSOMNIA)
CTRI/2014/04/004520ATIONAL INSTITUTE OF SIDDHA10
Completed
Phase 2
Siddha treatment for Joint pai
CTRI/2010/091/006125ational Institute of Siddha Chennai Tamil Nadu India40
Not Yet Recruiting
Phase 2
A Study to find the Effectiveness of Siddha treatment for Vathakarsanam (Diabetic Peripheral Neuropathy)Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
CTRI/2024/06/069492I
Not Yet Recruiting
Phase 2
A Pilot Clinical study of Siddha Medicine in the treatment of Pen Maladu (Female Infertility)
CTRI/2017/03/008067ational Institute of Siddha10
Completed
Phase 2
Study of a combination of fenugreek/phaseolamin as a new weight loss agentObesityDiet and Nutrition - Obesity
ACTRN12607000130460Southern European Health Marketing Ltd39